XML 26 R30.htm IDEA: XBRL DOCUMENT v2.4.0.8
16. Restatement of Prior Period Financials (Tables)
3 Months Ended
Mar. 31, 2014
Accounting Changes and Error Corrections [Abstract]  
Effect of Corrections

 

Effect of Corrections   As Previously             As  
    Reported     Adjustments       Restated  
Balance Sheet as of December 31, 2013                    
Convertible notes payable (net of debt discount) – current portion   $ 2,930     $ 2,426   (1)   $ 5,356  
Total current liabilities     46,142       2,426   (1)     48,568  
Convertible notes payable (net of debt discount), less current portion     341,907       268,043   (1)     609,950  
Total long-term liabilities     343,157       268,043   (1)     611,200  
Common stock     1,204,096       (270,469 ) (2)     933,627  
Total stockholders’ equity     493,134       (270,469 ) (2)     222,665  
Statement of Changes in Stockholders’ Equity for the Period from June 5, 2013 (Inception) to December 31, 2013                          
Discount on convertible notes December 27, 2013     289,811       (270,469 )   (2)     19,342  
Common stock     1,204,096       (270,469 ) (2)     933,627  
Total stockholders’ equity     493,134       (270,469 ) (2)     222,665  

 

 

Effect of Corrections As Previously            
  Reported   Adjustments     As Restated  
Balance Sheet as of March 31, 2014:                
Deferred financing costs, net   $ 115,000   $ (6,000 ) (3) $ 109,000  
Total Assets     2,532,925     (6,000 ) (8)   2,526,925  
Derivative liability     -     1,147,640   (5)   1,147,640  
Accounts payable and accrued expenses     32,813     (6,000 ) (3)   26,813  
Total current liabilities     38,740     1,141,640   (8)   1,180,380  
Convertible notes payable, net     402,595     254,888   (1)   657,483  
Total long-term liabilities     403,845     254,888   (8)   658,733  
Total liabilities     442,585     1,396,528   (8)   1,839,113  
Common stock     3,375,165     (770,469 ) (11)   2,604,696  
Deficit accumulated during the development stage     (1,284,825 )   (632,059 ) (10)   (1,916,884 )
Total Stockholders' Equity     2,090,340     (1,402,528 ) (8)   687,812  
Total Liabilities & Stockholders' Equity     2,532,925     (6,000 ) (8)   2,526,925  
Statement of Operations for the three months ended March 31, 2014:                      
Amortization of debt discount     (320,422 )   15,581   (4)   (304,841 )
Gain (loss) on derivative liability, net     -     (647,640 ) (8)   (647,640 )
Total other expense     (369,696 )   (632,059 ) (8)   (1,001,755 )
Net loss     (573,863 )   (632,059 ) (8)   (1,205,922 )
Net loss per share - basic and diluted     (0.04 )   (0.05 ) (9)   (0.09 )
Statement of Operations for the period from Inception (June 5, 2013) to March 31, 2014                
Amortization of debt discount     (321,216 )   15,581   (4)   (305,635 )
Gain (loss) on derivative liability, net     -     (647,640 ) (6)   (647,640 )
Total other expense     (371,361 )   (632,059 ) (8)   (1,003,420 )
Loss from continuing operations     (1,286,782 )   (632,059 ) (8)   (1,918,841 )
Net loss     (1,284,825 )   (632,059 ) (8)   (1,916,884 )
Statement of Cash Flows for the three months ended March 31, 2014:                      
Net loss     (573,863 )   (632,059 ) (8)   (1,205,922 )
Amortization of debt discount     320,422     (15,581 ) (4)   304,841  
Amortization of deferred financing costs     -     6,000   (3)   6,000  
(Gain) loss on derivative liability, net     -     647,640   (6)   647,640  
Increase/ (decrease) in accounts payable and accrued expenses     (11,193 )   (5,206 ) (3)   (16,399 )
Net cash provided by (used in) operating activities – continuing operations     (330,777 )   794   (8)   (329,983 )
Net cash provided by (used in) operating activities     (330,777 )   794   (8)   (329,983 )
Principal repayment on convertible notes payable     (943 )   (794 ) (4)   (1,737 )
Statement of Cash Flows for the period from Inception (June 5, 2013) to March 31, 2014:                
Net loss     (1,284,825 )   (632,059 ) (8)   (1,916,884 )
Amortization of debt discount     321,216     (15,581 ) (4)   305,635  
Amortization of deferred financing costs     -     6,000   (3)   6,000  
(Gain) loss on derivative liability, net     -     647,640   (6)   647,640  
Increase/ (decrease) in accounts payable and accrued expenses     32,019     (5,206 ) (3)   26,813  
Net cash provided by (used in) operating activities – continuing operations     (809,977 )   794   (8)   (809,183 )
Net cash provided by (used in) operating activities     (819,848 )   794   (8)   (819,054 )
Principal repayment on convertible notes payable     (943 )   (794 ) (4)   (1,737 )
Statement of Changes in Stockholders' Equity for the period from Inception (June 5, 2013) to March 31, 2014:          
Discount on convertible notes issued December 27, 2013     289,811     (270,469 ) (2)   19,342  
Common stock at December 31 , 2013     1,204,096     (270,469 ) (8)   933,627  
Warrants sold to Full Circle January, 2014 in financing transaction     500,000     (500,000 ) (7)   -  
Common stock at March 31, 2014     3,375,165     (770,469 ) (8)   2,604,696  
Net loss for three months ended March 31, 2014     (573,863 )   (632,059 ) (8)   (1,205,922 )
Total Stockholders' Equity     2,090,340     (1,402,528 ) (8)   687,812  

 

 

(1)   To reclassify debt discount, net of amortization, previously recognized as a beneficial conversion feature to current and noncurrent convertible notes payable from discount on convertible notes and common stock.

 

(2)   To reclassify debt discount, net of amortization, previously recognized as a beneficial conversion feature from discount on convertible notes and common stock to current and noncurrent convertible notes payable.

 

(3)   To present amortization expense recognized on deferred financing costs as its own line item in the statement of cash flows and reclassify it from Increase/ (decrease) in accounts payable and accrued expenses.

 

(4)   To recognize amortization of debt discount and reclassify amounts repaid on the principal of the convertible notes.

 

(5)   To record derivative liability at March 31, 2014.

 

(6)   To present the loss on the warrant derivative liability.

 

(7)   To derecognize the warrants sold to Full Circle which were erroneously recorded as adjustments to common stock.

 

(8)   To present the cumulative impact of adjustments discussed above.  This is a line item is a subtotal or total balance on the financial statements.

 

(9)   To present the cumulative impact of adjustments on the net loss per share.

 

(10)   To present the cumulative impact of adjustments on the Company’s deficit accumulated during the development stage.

 

(11)   To present the cumulative impact of adjustments relating to items (7) and (2).